Prognostic value of apoptosis-associated speck-like protein containing a CARD gene promoter methylation in resectable non-small-cell lung cancer

Clinical Lung Cancer

Volumn 8, Issue 1, 2006, Pages 62-65

  Zhang, Zhixue ^a   Tan, Sheng ^a   Zhang, Lin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Adenocarcinoma; Bilobectomy; Methylation specific polymerase chain reaction

Indexed keywords

APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN CONTAINING A CARD; BIOLOGICAL MARKER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE INACTIVATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 33748357288     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2006.n.035     Document Type: Article

References (33)

1. Greenlee RT, Hill-Harmon MB, Muray T. Cancer statistics, 2001. CA Cancer J Clin 2001; 51:15-36.
2. Ginsberg RJ, Vokes EE, Rabin A. Non-small cell lung cancer. In: DeVita VT, Hellmann S, Rosenberg SA, eds. Cancer: Principles in Practice of Oncology. 5th ed. Philadelphia, PA: Lipincott-Raven Publishers; 1997:858-910.
3. Niklinski J, Niklinska W, Laudanski J. Prognostic molecular markers in non-small cell lung cancer. Lung Cancer 2001; 34:S53-S58.
4. Fong KM, Sekido Y, Gazdar AF. Lung cancer molecular biology of lung cancer: clinical implications. Thorax 2003; 58:892-900.
5. Hirsch FR, Franklin WA, Gazdar AF, et al. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001; 7:5-22.
6. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002; 64:681-708.
7. Forgacs E, Zochbauer-Muller S, Olah E, et al. Molecular genetic abnormalities in the pathogenesis of human lung. Pathol Oncol Res 2001; 7:6-13.
8. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/ CDKN2/ MTS1 in human cancers. Nat Med 1995; 1:686-692.
9. Laìrd PW, Jaenisch R. The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 1996; 30:441-464.
10. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72:141-196.
11. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21:163-167.
12. Esteller M, Sparks A, Toyota M, et al. Analysis of adenomatous polyposis promoter hypermethylation in human cancer. Cancer Res 2000; 60:4366-4371.
13. Kawakami K, Brabender J, Lord RV, et al. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst (Bethesda) 2000; 92:1805-1811.
14. Tsuchiya T, Tamura G, Sato K, et al. Distinct methylation patterns of two ARC gene promoters in normal and cancerous gastric epithelia. Oncogene 2000; 19:3642-3646.
15. Wong DJ, Barrett MT, Stoger R, et al. p16ink4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res 1997; 57:2619-2622.
16. Klump B, Hsieh CJ, Holzmann K, et al. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterol 1998; 115:1381-1386.
17. Fleisher AS, Esteller M, Wang S, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999; 59:1090-1095.
18. Tamura G, Yin J, Wang S, et al. E-cadherin gene promoter hypermethylation in primary gastric carcinomas. J Natl Cancer Inst (Bethesda) 2000; 92:569-573.
19. Tang X, Khuri FR, Lee JJ, et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressivnes in stage I non-small cell lung cancer. J Natl Cancer Inst (Bethesda) 2000; 92:1511-1516.
20. Esteller M, Sanchez-Cespedes M, Rosell R, et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999; 59:67-70.
21. Esteller M, Hamilton SR, Burger PC, et al. Inactivation of the DNA repair gene O6-methylguanine- DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999; 59:793-797.
22. Brabender J, Usadel H, Danenberg KD, et al. Adenomatous polyposis gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 2001; 20:3528-3532.
23. Usadel H, Brabender J, Danenberg KD, et al. Quantitative APC-promoter methylation analysis in tumor tissues, serum and plasma DNA of patients with lung cancer. Cancer Res 2002; 62:371-375.
24. Masumoto J, Taniguchi S, Ayukawa K, et al. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem 1999; 274:33835-33838.
25. Conway KE, McConnell BB, Bowring CE, et al. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 2000; 60:6236-6242.
26. Herman JG, Graff JR, Myohanen S, et al. Menthylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821-9826.
27. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-1462.
28. Duelli DM, Lazebnik YA. Primary cells suppress oncogene-dependent apoptosis. Nat Cell Biol 2000; 2:859-862.
29. Juin P, Hueber AO, Littlewood T, et al. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev 1999; 13:1367-1381.
30. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
31. Virmani A, Rathi A, Sugio K, et al. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer 2003; 106:198-204.
32. Jun-ichi Akahira, Youko Sugihashi, Kiyoshi Ito, et al. Promoter methylation status and expression of TMS1 gene in human epithelial ovarian cancer. Cancer Sci 2004; 95:40-43.
33. Zöchbauer-Müller S, Fong KM, Virmani AK, et al. D. Aberrant promoter methylation of multiple genes in non-small cell lung cancer. Cancer Res 2001; 61:249-255.